Abraham Pinter

10.0k total citations · 1 hit paper
117 papers, 5.0k citations indexed

About

Abraham Pinter is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Abraham Pinter has authored 117 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Virology, 56 papers in Infectious Diseases and 48 papers in Immunology. Recurrent topics in Abraham Pinter's work include HIV Research and Treatment (66 papers), Monoclonal and Polyclonal Antibodies Research (32 papers) and HIV/AIDS drug development and treatment (31 papers). Abraham Pinter is often cited by papers focused on HIV Research and Treatment (66 papers), Monoclonal and Polyclonal Antibodies Research (32 papers) and HIV/AIDS drug development and treatment (31 papers). Abraham Pinter collaborates with scholars based in United States, Japan and Switzerland. Abraham Pinter's co-authors include William Honnen, Samuel C. Kayman, Susan Zolla‐Pazner, Miroslaw K. Górny, S A Tilley, Chavdar Krachmarov, Erwin Fleissner, Kathy Revesz, James E. Robinson and Yuxian He and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Abraham Pinter

114 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus.

1991 303 citations Abraham Pinter et al. profile →

Peers

Countries citing papers authored by Abraham Pinter

Since Specialization

Citations

This map shows the geographic impact of Abraham Pinter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham Pinter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham Pinter more than expected).

Fields of papers citing papers by Abraham Pinter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abraham Pinter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham Pinter. The network helps show where Abraham Pinter may publish in the future.

Co-authorship network of co-authors of Abraham Pinter

This figure shows the co-authorship network connecting the top 25 collaborators of Abraham Pinter. A scholar is included among the top collaborators of Abraham Pinter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abraham Pinter. Abraham Pinter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-world diagnostic accuracy of lipoarabinomannan in three non-sputum biospecimens for pulmonary tuberculosis disease 2024 ·EBioMedicine ·Paul K. Drain, (unknown), Adrienne E. Shapiro, (unknown), (unknown), (unknown), Katherine K. Thomas, (unknown), Jennifer F. Morton, (unknown), Abraham Pinter, Jason L. Cantera, Caitlin E. Anderson, (unknown), (unknown), (unknown)	3
2	Predictors of chronic COVID-19 symptoms in a community-based cohort of adults 2022 ·PLoS ONE ·Jonathan I. Silverberg, Israel Zyskind, Hiam Naiditch, (unknown), Aaron E. Glatt, Abraham Pinter, Elitza S. Theel, Michael J. Joyner, D. Ashley Hill, Miriam Lieberman, (unknown), (unknown), Elliot Frank, Avi Z. Rosenberg	14
3	Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis 2022 ·PLoS ONE ·Jason L. Cantera, (unknown), Roger Peck, Emmanuel Moreau, James Schouten, Paul J. Davis, Paul K. Drain, Alfred Andama, Abraham Pinter, Masanori Kawasaki, Gunilla Källenius, Christopher Sundling, Karen M. Dobos, (unknown), Delphi Chatterjee, Eileen Murphy, (unknown), David S. Boyle	5
4	A pandemic-enabled comparison of discovery platforms demonstrates a naive antibody library can match the best immune-sourced antibodies 2022 ·Nature Communications ·Fortunato Ferrara, (unknown), Sara D’Angelo, (unknown), André A. Teixeira, Alok Choudhary, William Honnen, David Calianese, Deli Huang, (unknown), James E. Voss, David Nemazee, Dennis R. Burton, Abraham Pinter, Andrew Bradbury	24
5	Diagnostic accuracy of 3 urine lipoarabinomannan tuberculosis assays in HIV-negative outpatients 2020 ·Journal of Clinical Investigation ·Tobias Broger, Mark P. Nicol, George B. Sigal, Eduardo Gotuzzo, A. Zimmer, (unknown), (unknown), (unknown), Elena Ivanova Reipold, Rita Székely, (unknown), (unknown), (unknown), Kinuyo Chikamatsu, Todd L. Lowary, Abraham Pinter, Satoshi Mitarai, Emmanuel Moreau, Samuel G. Schumacher, Claudia M. Denkinger	47
6	Characterization of the Antigenic Heterogeneity of Lipoarabinomannan, the Major Surface Glycolipid of Mycobacterium tuberculosis, and Complexity of Antibody Specificities toward This Antigen 2018 ·The Journal of Immunology ·Alok Choudhary, Deendayal Patel, William Honnen, Zhong Lai, (unknown), Ruixiang Blake Zheng, (unknown), Maria Laura Gennaro, Alfred Lardizabal, Blanca I. Restrepo, (unknown), Maju Joe, Yu Bai, Ke Shen, (unknown), John S. Spencer, Delphi Chatterjee, Tobias Broger, Todd L. Lowary, Abraham Pinter	50
7	Vaccination with Vaxfectin ^® adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia 2013 ·Human Vaccines & Immunotherapeutics ·Viraj Kulkarni, Margherita Rosati, Antonio Valentin, Rashmi Jalah, Candido Alicea, Lei Yu, Yongjun Guan, Xiaoying Shen, Georgia D. Tomaras, Celia C. LaBranche, David C. Montefiori, Carmela Irene, (unknown), Abraham Pinter, Seán M. Sullivan, George N. Pavlakis, Barbara K. Felber	10
8	Specific sequences commonly found in the V3 domain of HIV-1 subtype C isolates affect the overall conformation of native Env and induce a neutralization-resistant phenotype independent of V1/V2 masking 2013 ·Virology ·(unknown), Chavdar Krachmarov, Zhong Lai, William Honnen, Barry S. Zingman, (unknown), Miroslaw K. Górny, Susan Zolla‐Pazner, James E. Robinson, Abraham Pinter	9
9	Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection 2010 ·Virology ·Rebecca M. Lynch, Rong Rong, Bing Li, Tongye Shen, William Honnen, Joseph Mulenga, Susan Allen, Abraham Pinter, S. Gnanakaran, Cynthia A. Derdeyn	16
10	Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold 2010 ·Virology ·Maxim Totrov, Xunqing Jiang, Xiang‐Peng Kong, Sandra Cohen, Chavdar Krachmarov, (unknown), Constance Williams, Michael S. Seaman, Timothy Cardozo, Miroslaw K. Górny, Shixia Wang, Shan Lu, Abraham Pinter, Susan Zolla‐Pazner	38
11	Worldwide Distribution of HIV Type 1 Epitopes Recognized by Human Anti-V3 Monoclonal Antibodies 2009 ·AIDS Research and Human Retroviruses ·Timothy Cardozo, (unknown), Abraham Pinter, Chavdar Krachmarov, Arthur Nádas, (unknown), Susan Zolla‐Pazner	23
12	Escape from Autologous Neutralizing Antibodies in Acute/Early Subtype C HIV-1 Infection Requires Multiple Pathways 2009 ·PLoS Pathogens ·Rong Rong, Bing Li, Rebecca M. Lynch, Richard E. Haaland, (unknown), Joseph Mulenga, Susan Allen, Abraham Pinter, George M. Shaw, Eric Hunter, James E. Robinson, S. Gnanakaran, Cynthia A. Derdeyn	140
13	Human Immunodeficiency Virus Type 2 (HIV-2)/HIV-1 Envelope Chimeras Detect High Titers of Broadly Reactive HIV-1 V3-Specific Antibodies in Human Plasma 2008 ·Journal of Virology ·Katie L. Davis, Frédéric Bibollet‐Ruche, Hui Li, Julie M. Decker, Olaf Kutsch, Lynn Morris, (unknown), Abraham Pinter, James A. Hoxie, Beatrice H. Hahn, Peter D. Kwong, George M. Shaw	55
14	Opposite Immune Reactivity of Serum IgG and Secretory IgA to Conformational Recombinant Proteins Mimicking V1/V2 Domains of Three Different HIV Type 1 Subtypes Depending on Glycosylation 2008 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), Willy Berlier, Nadine Vincent, Silvio Urcuqui‐Inchima, F. Lucht, (unknown), Abraham Pinter, Christian Genin, Serge Riffard	4
15	Peptides Selected from a Phage Display Library with an HIV-Neutralizing Antibody Elicit Antibodies to HIV gp120 in Rabbits, But Not to the Same Epitope 2007 ·AIDS Research and Human Retroviruses ·Royce A. Wilkinson, (unknown), Jon Jacobs, (unknown), Seth H. Pincus, Abraham Pinter, Charles A. Parkos, James B. Burritt, Martin Teintze	9
16	Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope 2007 ·Virology ·Susan Zolla‐Pazner, Sandra Cohen, Chavdar Krachmarov, Shixia Wang, Abraham Pinter, Shan Lu	52
17	Session 6: Infectious disease 2006 ·Human Antibodies ·Roberto Burioni, (unknown), Miroslaw K. Górny, Tetsuya Kimura, Barbara Volsky, Kathy Revesz, Constance Williams, William Honnen, Chavdar Krachmarov, Abraham Pinter, (unknown), (unknown)	1
18	Characterization of antibodies that inhibit HIV gp120 antigen processing and presentation 2005 ·European Journal of Immunology ·Michael Tuen, Maria Luisa Visciano, Peter Chien, Sandra Cohen, (unknown), James E. Robinson, Yuxian He, Abraham Pinter, Miroslaw K. Górny, Catarina E. Hioe	24
19	Efficient Isolation of Novel Human Monoclonal Antibodies with Neutralizing Activity Against HIV-1 from Transgenic Mice Expressing Human Ig Loci 2002 ·The Journal of Immunology ·Yuxian He, William Honnen, Chavdar Krachmarov, (unknown), Samuel C. Kayman, José R. F. Corvalán, Abraham Pinter	47
20	Identification of Large Glycosylated Proteins Recognized by Monoclonal Antibodies Against HIV-1 gag Proteins 1992 ·AIDS Research and Human Retroviruses ·Abraham Pinter, William Honnen, Kathy Revesz, Ruth Herz	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact